MedPath

Blueprint Medicines (Netherlands) BV

🇳🇱Netherlands
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

CIMA_AEMPS:6
EMA:3
EMC:2

Drug Approvals

Gavreto

Authorization Status
Withdrawn
Approval Date
Nov 18, 2021
EMA

Ayvakyt

Authorization Status
Authorised
Approval Date
Sep 24, 2020
EMA

Ayvakyt

Authorization Status
Authorised
Approval Date
Sep 24, 2020
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.